No Data
No Data
Anxubio (688075.SH) granted 1.195 million restricted stocks at a grant price of 17.32 yuan per share.
Anxuesheng Biology (688075.SH) announced that the second board of directors meeting held on October 11, 2024...
Assure Tech (Hangzhou)'s (SHSE:688075) Soft Earnings Are Actually Better Than They Appear
Anxu Biotech 2024 Semi-Annual Report
Summary of Anxu Biotech\'s 2024 Semi-Annual Report
Anxu Biology (688075.SH) released its performance in the first half of the year, with a net income of 0.115 billion yuan, a year-on-year decrease of 30.85%.
Anxu Bio (688075.SH) released its 2024 interim report, with revenue of 0.248 billion yuan for the company,...
Anxubio (688075.SH): net income in the first half of the year was 0.115 billion yuan, a year-on-year decrease of 30.85%.
On August 29, Axcy Biotech (688075.SH) released its semi-annual report. The company achieved revenue of 248.1567 million yuan, a 21.42% increase compared to the same period last year. The net income attributable to the owners of the parent company was 115.319 million yuan, a decrease of 30.85% compared to the same period last year. The net income attributable to the owners of the parent company after deducting non-recurring gains and losses was 18.885 million yuan, a decrease of 80.95% compared to the same period last year. At the end of the reporting period, the company's total assets reached 5796.4535 million yuan, a year-on-year increase of 0.12%; attributable to the owners of the parent company...
No Data
No Data